Durvalumab vs Fentanyl

Durvalumab vs Fentanyl: Overview

This comparison examines the pharmacological differences between Durvalumab and Fentanyl.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Fentanyl: Highly potent synthetic mu-opioid receptor agonist approximately 100 times more potent than morphine.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Fentanyl — 2-4 hours.

Chemical Properties

Molecular Formula: Fentanyl — C22H28N2O.

Molecular Weight: Fentanyl — 336.4700 g/mol.

Type: Durvalumab — Antibody; Fentanyl — Small molecule.